• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Parmax Pharma Ltd — Board Meeting, 14-02-2026: Board Meeting

    14-02-2026 | 08:33 pm

    Parmax Pharma's board approved financial results for the quarter and nine months ended Dec 31, 2025. Revenue reached ₹4.32 Cr (Q) and ₹8.79 Cr (9M). The company posted a net loss of ₹0.73 Cr for the quarter and ₹3.57 Cr for the nine months, with EPS at ₹-1.96 (Q) and ₹-9.55 (9M).

    No comments yet. Be the first to comment!

    All announcements from Parmax Pharma Ltd